about
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseA fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivoNuclear antisense effects of neutral, anionic and cationic oligonucleotide analogsA peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulationCell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic AcidIntracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination StrategiesDepot-Based Delivery Systems for Pro-Angiogenic Peptides: A ReviewCell-penetrating peptides and their analogues as novel nanocarriers for drug deliveryOrganelle targeting: third level of drug targetingSolution NMR studies on the orientation of membrane-bound peptides and proteins by paramagnetic probesStructure and positioning comparison of two variants of penetratin in two different membrane mimicking systems by NMRThe 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulationUnique membrane interaction mode of group IIF phospholipase A2Current approaches to enhance CNS delivery of drugs across the brain barriersRegulation of ghrelin structure and membrane binding by phosphorylation.Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins.Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypesMembrane translocation of penetratin and its derivatives in different cell lines.Amphipathic peptides and drug delivery.Cellular uptake of antisense oligonucleotides after complexing or conjugation with cell-penetrating model peptides.The use of fullerene substituted phenylalanine amino acid as a passport for peptides through cell membranes.How to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo (Review).Peptide-mediated cellular uptake of cryptophane.Identification and characterization of a novel cell-penetrating peptideEfficient CPP-mediated Cre protein delivery to developing and adult CNS tissuesInduction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice.Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein.Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotidesSpecific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.Enhancement of intracellular delivery of anti-cancer drugs by the Tat peptide.Scorpion venom components that affect ion-channels functionDevelopment of inhibitors of heterotrimeric Gαi subunitsMacromolecular uptake is a spontaneous event during mitosis in cultured fibroblasts: implications for vector-dependent plasmid transfection.CNS delivery via adsorptive transcytosis.Imperatoxin A, a Cell-Penetrating Peptide from Scorpion Venom, as a Probe of Ca-Release Channels/Ryanodine Receptors.Tat-Mediated Peptide Intervention in Analgesia and Anesthesia.Potential use of non-classical pathways for the transport of macromolecular drugs.Agile delivery of protein therapeutics to CNSNeedle-shaped polymeric particles induce transient disruption of cell membranes.Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion
P2860
Q22248091-CD7B20E7-03F6-4526-AA46-E35E3F69F1D2Q24530544-24EAC0D4-839E-4C37-8FC6-7913A647C7CEQ24555118-1AC8EDF5-A493-4693-B52F-E44448EED701Q24600240-B49584C6-F712-4156-B264-98D9181EB7ECQ26774462-37839CD2-AE3B-44BC-B50D-B08B7943A659Q26795943-D9847D8A-A6C5-4FEE-A667-4BF959D60027Q26799856-C452AE1A-9F2E-45A0-B88F-6D231A76EFF9Q26801860-13E77549-E2F8-482D-88DA-560DC9AB2889Q27014902-1FBEB671-6A9D-482B-9B81-642D8CFE60B3Q27024724-974D150E-E860-4428-9C2A-96D52D30074AQ27641644-C34C84BD-CE26-4374-9B83-9FE402571B64Q28299353-90D8A358-7E92-487A-90E2-0AE0D1DE3712Q28511917-9D302662-CEFB-490F-B1CE-86C307EE6B6FQ30437835-0E345F34-B436-49BE-BF50-2CDDD5D1E61AQ30439568-9493E673-2E98-4C41-AFD0-CCEB052D4C72Q30447412-B75AD5D9-6993-4E0A-AE39-14802B278D9DQ30536567-BBDFEA2B-CE8B-4468-9F5E-D78F2EBA95FEQ30881434-07F5A103-8E88-4F56-87F3-2A109712E7AFQ30917891-785A64E3-18F6-42C7-A7CF-A736F9772152Q31104360-42906B6F-F331-4ACC-9290-ED2ADC34ADF6Q33268306-ED4823B0-DA01-4DD7-8D73-4510B3711FFDQ33285497-70E577CA-845C-439F-921F-F1E8D1F536E2Q33377228-B021BFFB-CFFA-437C-848F-5DAAF24356D6Q33393157-C75192D6-BEAD-443B-A01D-916EBC2055D7Q33434938-12691379-9D81-4BEA-A218-1E2CEAF0484EQ33730763-D68EB2D7-6D6D-4A39-86C8-9F29BDCE2797Q33751225-3C37E78F-8BFD-49B1-A71E-35C8A4A2C664Q33754501-0EC5D794-B733-472C-B844-A7D9B15FC82BQ33823337-82E2C3AB-A879-4CA5-AB14-741DC3987681Q33846530-0724FAB5-335F-4BD9-A76D-BBD443817371Q33871187-3903ECAA-A432-4DC7-9BE1-FB0C3AD7E977Q33920486-FB439870-9FCC-416F-BB2F-B1E805098BE0Q33953717-12BE1FFC-2F3C-4C3C-9DC8-6EB653C2E9B6Q34013526-E9437136-1730-4C97-B357-329C51401635Q34021802-C3CFF7F8-6DFF-408D-90BF-DF1F7C4E160BQ34054988-E31DC8BF-A598-48E2-898F-990F12885F42Q34075054-2C2B9430-2E1B-465B-907F-FEDD31868B6FQ34079647-4166B09B-A419-4B50-83EF-650127C81AA3Q34147654-E83B52BE-E908-4DE9-800D-AF92019A93E2Q34148181-C34D7EAF-42D2-49DB-A295-C9C96006293F
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cell-penetrating peptides.
@ast
Cell-penetrating peptides.
@en
type
label
Cell-penetrating peptides.
@ast
Cell-penetrating peptides.
@en
prefLabel
Cell-penetrating peptides.
@ast
Cell-penetrating peptides.
@en
P2093
P1476
Cell-penetrating peptides
@en
P2093
A Prochiantz
M Hällbrink
M Lindgren
P304
P356
10.1016/S0165-6147(00)01447-4
P50
P577
2000-03-01T00:00:00Z